Alan F. Denenberg
Lawyers
Filters
Revolution Medicines $1 billion at-the-market offering
We advised the sales agent on the offering
Recursion Pharmaceuticals $300 million at-the-market offering
We advised the sales agent on the offering
Coherus Oncology $50 million follow-on offering
We advised the joint book-running managers and representatives of the underwriters on the offering
Alphabet £5.5 billion debut sterling notes offering
We advised the global coordinators and book-running managers on the offering
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Microchip Technology $900 million convertible notes offering
We advised the initial purchasers on the offering and advised counterparties to related capped call transactions
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
Ambiq Micro $83.1 million follow-on offering
We advised the underwriters on the offering
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
Tenaya Therapeutics $60 million units offering
We advised the joint book-running managers and representatives of the several underwriters